Top Markets
Coin of the day
Burzynski Research Institute, Inc. Burzynski Research Institute, Inc.

Burzynski Research Institute, Inc.

BZYR
Rangering i aksjer #39233
Burzynski Research Institute, Inc. engages in the research and development of... Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.
Aksjekurs
$0.0045
Sist synkronisert: 2026-08-13
Markedsverdi
$591.52K
Endring (1 dag)
-10.00%
Endring (1 år)
-86.76%
Land
US
Handel Burzynski Research Institute, Inc. (BZYR)

Kategori

EPS for Burzynski Research Institute, Inc. (BZYR)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Burzynski Research Institute, Inc. er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Burzynski Research Institute, Inc. fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter